All Stories

  1. Antimicrobial resistance genes and antibiotic use in chronic lung disease: a bronchoscopy study of the lower airways microbiome

    Article • BMJ Open Respiratory Research, March 2026, BMJ

    Phd, MD Solveig Tangedal

  2. Gut microbiota in chronic obstructive pulmonary disease varies by CT-verified emphysema status

    Article • European Clinical Respiratory Journal, February 2025, Taylor & Francis

    Phd, MD Solveig Tangedal

  3. Airway microbiota as a biomarker in predicting COPD and control

    Article • September 2024, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  4. Presence of antibiotic resistance genes in the lower airways microbiome of patients with chronic lung disease and healthy controls

    Article • September 2024, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  5. Lower airway microbiota in COPD and healthy controls

    Article • Thorax, February 2024, BMJ

    Phd, MD Solveig Tangedal

  6. Is the lower airways microbiome associated with coronary calcification?

    Article • September 2023, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  7. The lower airways microbiota and antimicrobial peptides indicate dysbiosis in sarcoidosis

    Article • Microbiome, October 2022, Springer Science + Business Media

    Phd, MD Solveig Tangedal

  8. Is the oral microbiota representative for the healthy bronchial microbiota?

    Article • September 2022, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  9. The gut microbiome in COPD; a case-control study

    Article • September 2022, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  10. A longitudinal study of the pulmonary mycobiome in subjects with and without chronic obstructive pulmonary disease

    Article • PLOS One, May 2022, PLOS

    Einar Marius Hjellestad Martinsen, Phd, MD Solveig Tangedal

  11. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease

    Article • PLOS One, January 2022, PLOS

    Phd, MD Solveig Tangedal

  12. The pulmonary bacterial and fungal microbiota in sarcoidosis patients

    Article • September 2021, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  13. Guilty pleasures and the healthy lung microbiota

    Article • September 2020, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  14. The airway microbiota and exacerbations of COPD

    Article • ERJ Open Research, July 2020, European Respiratory Society (ERS)

    Elise Leiten, Phd, MD Solveig Tangedal

  15. Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels

    Article • September 2019, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  16. Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients

    Article • PLOS One, September 2019, PLOS

    Phd, MD Solveig Tangedal

  17. Comparing microbiota profiles in induced and spontaneous sputum samples in COPD patients

    Article • August 2017, Springer Science + Business Media

    Phd, MD Solveig Tangedal

  18. Protected sampling is preferable in bronchoscopic studies of the airway microbiome

    Article • ERJ Open Research, July 2017, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  19. MIG and IP-10 levels in induced sputum of stable and exacerbated COPD patients

    Article • September 2015, European Respiratory Society (ERS)

    Phd, MD Solveig Tangedal

  20. Comparison of inflammatory markers in induced and spontaneous sputum in a cohort of COPD patients

    Article • November 2014, Springer Science + Business Media

    Phd, MD Solveig Tangedal

  21. Is elevated pre-ictal heart rate associated with secondary generalization in partial epilepsy?

    Article • Seizure, June 2010, Elsevier

    Phd, MD Solveig Tangedal